" class="no-js "lang="en-US"> Bud Flagstad - Medtech Alert
Thursday, November 30, 2023

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Bud Flagstad

Bud Flagstad

About Bud Flagstad

Experienced Vice President Software with a demonstrated history of working in the health care industry. Strong support professional skilled in M&A, Sales, Medical Manufacturing, IT Strategy, Professional Services, Healthcare Services, Technology, Management, Innovation, System Thinking, and Project Portfolio Management.

Related Story

Appointments

 Steven Penn Joins Care Angel as Chief Financial Officer/Chief Operations Officer

Steven Penn Joins Care Angel as Chief Financial Officer/Chief Operations Officer

September 21 2021

Care Angel, the leader in AI and voice-enabled nurse assistant technology, today announced that Steven Penn has joined […]